Comparison of Human Tissue Gadolinium Retention and Elimination between Gadoteridol and Gadobenate [Gadolinium deposits in brain in both linear & macrocyclic agents] (2021).

Authors: Masahiro Kobayashi, MD, Nozomu Murata, MD, PhD, Kenneth R. Maravilla, MD, Swati Rane Levendovszky, PhD, Kiyoko Murata, MD, PhD, Daniel S. Hippe, MS, Desiree A. Marshall, MD, Makoto Hasegawa, MD, Luis F. Gonzalez-Cuyar, MD

Previous
Previous

Dynamic Serial Cytokine Measurements During Intravenous Ca-DTPA Chelation in Gadolinium Deposition Disease and Gadolinium Storage Condition: A Pilot Study (2022).

Next
Next

Toxicity of lanthanide coagulants assessed using four in vitro bioassays (Aug 2021).